Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.

Cheraghpour M, Imani H, Ommi S, Alavian SM, Karimi-Shahrbabak E, Hedayati M, Yari Z, Hekmatdoost A.

Phytother Res. 2019 Jul 1. doi: 10.1002/ptr.6406. [Epub ahead of print]

PMID:
31264313
3.

Hypomethylation of NANOG promoter in colonic mucosal cells of obese patients: a possible role of NF-κB - CORRIGENDUM.

Sedaghat F, Cheraghpour M, Hosseini SA, Pourvali K, Teimoori Toolabi L, Mehrtash A, Talaei R, Zand H.

Br J Nutr. 2019 Jan 11:1. doi: 10.1017/S0007114518003525. [Epub ahead of print] No abstract available.

PMID:
30630544
4.

Hypomethylation of NANOG promoter in colonic mucosal cells of obese patients: a possible role of NF-κB.

Sedaghat F, Cheraghpour M, Hosseini SA, Pourvali K, Toolabi LT, Mehrtash A, Talaei R, Zand H.

Br J Nutr. 2018 Aug 30:1-10. doi: 10.1017/S000711451800212X. [Epub ahead of print]

PMID:
30157990
5.

Hesperidin inhibits insulin-induced phosphoinositide 3-kinase/Akt activation in human pre-B cell line NALM-6.

Shahbazi R, Cheraghpour M, Homayounfar R, Nazari M, Nasrollahzadeh J, Davoodi SH.

J Cancer Res Ther. 2018 Apr-Jun;14(3):503-508. doi: 10.4103/0973-1482.157323.

6.

New anthropometric indices or old ones: Which is the better predictor of body fat?

Ehrampoush E, Arasteh P, Homayounfar R, Cheraghpour M, Alipour M, Naghizadeh MM, Hadibarhaghtalab M, Davoodi SH, Askari A, Razaz JM.

Diabetes Metab Syndr. 2017 Oct - Dec;11(4):257-263. doi: 10.1016/j.dsx.2016.08.027. Epub 2016 Aug 23.

PMID:
27578617
7.

Comments on "The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease".

Cheraghpour M, Hekmatdoost A, Ghaemi A.

Hepat Mon. 2016 Apr 30;16(5):e35162. doi: 10.5812/hepatmon.35162. eCollection 2016 May. No abstract available.

8.

Obesity-induced p53 activation in insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats.

Zand H, Homayounfar R, Cheraghpour M, Jeddi-Tehrani M, Ghorbani A, Pourvali K, Soltani SR.

Life Sci. 2016 Feb 15;147:103-9. doi: 10.1016/j.lfs.2016.01.040. Epub 2016 Jan 29.

PMID:
26827989
9.

Association of dietary patterns with body mass index, waist circumference, and blood pressure in an adult population in Ahvaz, Iran.

Haidari F, Shirbeigi E, Cheraghpour M, Mohammadshahi M.

Saudi Med J. 2014 Sep;35(9):967-74.

PMID:
25228178
10.

Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic and oncogenic signaling of insulin.

Homayounfar R, Jeddi-Tehrani M, Cheraghpour M, Ghorbani A, Zand H.

Gen Comp Endocrinol. 2015 Apr 1;214:134-9. doi: 10.1016/j.ygcen.2014.06.029. Epub 2014 Jul 10.

PMID:
25016051

Supplemental Content

Loading ...
Support Center